MMXBX Performance — MassMutual Select T. Rowe Price Retirement 2010 Fund, Class I
Data updated: 2025-08-25
MMXBX returned +9.22% over one year to Jun 2025. Annualised returns are +8.96% over 3 years and +6.42% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $129, against $141 for the category, and to $109 over one year, against $112. Volatility over the past three years was 8.84% a year. In the 12 months to Jun 2025 the fund lost a net $51.7M, and assets reached $46.41M.
MMXBX Growth of $100
What $100 invested in MassMutual Select T. Rowe Price Retirement 2010 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | MMXBX | Category average |
|---|---|---|
| 1 year (Jul 2024 – Jun 2025) | $109 | $112 |
| 3 years (Jul 2022 – Jun 2025) | $129 | $141 |
| 5 years (Jul 2020 – Jun 2025) | $137 | $154 |
| Since data start (Jul 2019 – Jun 2025) | $143 | $159 |
MMXBX Trailing Returns
Total returns to Jun 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +9.22% |
| 3 years (annualised) | +8.96% |
| 5 years (annualised) | +6.42% |
MMXBX Annual Returns
Calendar-year total returns of MassMutual Select T. Rowe Price Retirement 2010 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Jun) | +5.66% |
| 2024 | +8.70% |
| 2023 | +12.54% |
| 2022 | −13.85% |
| 2021 | +8.82% |
| 2020 | +12.01% |
| 2019 (Jul–Dec) | +5.19% |
MMXBX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | −1.4% | +0.7% | +1.9% | +0.1% | +2.0% | +2.3% | — | — | — | — | — | — |
| 2024 | +2.1% | +1.9% | 0.0% | +0.9% | +2.5% | −2.1% | +1.3% | +1.7% | +1.8% | −2.2% | +2.4% | −1.6% |
| 2023 | +1.9% | −1.9% | +4.3% | +2.6% | −1.0% | +0.9% | −2.7% | −1.4% | +1.9% | +3.9% | +5.5% | −1.6% |
| 2022 | 0.0% | −1.5% | −3.2% | −4.9% | 0.0% | −5.1% | −6.2% | −2.7% | +4.2% | −2.1% | +4.7% | +2.6% |
| 2021 | +1.2% | +1.1% | −0.2% | +0.7% | +0.9% | +2.4% | −2.1% | +1.2% | +0.8% | +1.7% | −1.4% | +2.3% |
| 2020 | −9.1% | −2.7% | +0.1% | +2.1% | +3.2% | +6.6% | −1.6% | +2.6% | +3.2% | +2.7% | +6.1% | −0.8% |
| 2019 | — | — | — | — | — | — | +0.5% | +0.1% | +0.3% | +1.8% | +1.2% | +1.1% |
MMXBX Risk
Risk measures from monthly returns over Jul 2022 – Jun 2025.
- 3-year volatility (annualised): 8.84%
- 3-year Sharpe ratio: 0.50 (vs 4.5% risk-free rate)
- Best month: +5.46% (Nov 2023)
- Worst month: −6.17% (Jul 2022)
MMXBX Fund Flows
Monthly money in and out of MassMutual Select T. Rowe Price Retirement 2010 Fund, from SEC Form N-PORT.
- 12-month net flow: −$51.7M
- 12-month gross sales (incl. reinvestments): $12.8M
- Sales ÷ redemptions: 0.20×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2025 | $195K | $882K | −$687K |
| May 2025 | $1.5M | $6.6M | −$5.1M |
| Apr 2025 | $688K | $893K | −$205K |
| Mar 2025 | $508K | $30.4M | −$29.9M |
| Feb 2025 | $292K | $322K | −$30K |
| Jan 2025 | $375K | $6.2M | −$5.8M |
| Dec 2024 | $1.4M | $1.5M | −$93K |
| Nov 2024 | $834K | $1.9M | −$1.1M |
| Oct 2024 | $4.2M | $2.1M | $2.1M |
| Sep 2024 | $1.1M | $4.7M | −$3.6M |
| Aug 2024 | $951K | $5.9M | −$5.0M |
| Jul 2024 | $743K | $3.0M | −$2.3M |
MMXBX Assets Under Management
Net assets of MassMutual Select T. Rowe Price Retirement 2010 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-06-30 | $46.41M |
| 2025-03-31 | $50.50M |
| 2024-12-31 | $85.28M |
| 2024-09-30 | $89.05M |
| 2024-06-30 | $95.52M |
| 2024-03-31 | $101.85M |
| 2023-12-31 | $100.71M |
| 2023-09-30 | $96.84M |
| 2023-06-30 | $102.83M |
| 2023-03-31 | $104.63M |
| 2022-12-31 | $102.92M |
| 2022-09-30 | $103.26M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.